TST-003

N/A

Report date: 2023/12/08 14:03:58

Base Information

Drug NameTST-003
Drug Alias NameTST-003
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionGremlin-1 inhibitors
TargetsGremlin-1
Therapy Area/IndicationsSolid tumoursNeoplasm MetastasisColorectal Neoplasms +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Inactive CompaniesTranscenta Holding Ltd
Active IndicationsSolid tumoursNeoplasm MetastasisColorectal Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A